Pentoxifylline as Anti-Inflammatory in Patients With Rheumatoid Arthritis

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 2, 2025

Primary Completion Date

May 30, 2026

Study Completion Date

September 30, 2026

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Methotrexate

Methotrexate (MTX) is a chemotherapy agent and immune-system suppressant. It is used to treat cancer, autoimmune diseases, and ectopic pregnancies. Types of cancers it is used for including breast cancer, leukemia, lung cancer, lymphoma, gestational trophoblastic disease, and osteosarcoma. Methotrexate is also used to treat rheumatoid arthritis and other inflammatory conditions.

DRUG

Pentoxifylline

Pentoxifylline (also known as oxpentifylline) is a methylxanthine derivative with strong hemorrheologic effects. In the United States, it is primarily used to treat intermittent claudication. Studies in both humans and animals have demonstrated that pentoxifylline therapy induces various physiological changes at the cellular level

Trial Locations (1)

34511

RECRUITING

Faculty of Medicine, Al-Azhar University, Damietta

All Listed Sponsors
collaborator

Prof. Sahar Kamal Hegazy, Professor of Clinical Pharmacy, Faculty of Pharmacy - Tanta University

UNKNOWN

collaborator

Dr. Mustafa Adel Mustafa Elmenawy Lecturer of Rheumatology and Rehabilitation, Faculty of Medicine - El-Azhar University - Damietta

UNKNOWN

lead

Tanta University

OTHER